Clinical Trials Logo

Neurodermatitis, Atopic clinical trials

View clinical trials related to Neurodermatitis, Atopic.

Filter by:
  • None
  • Page 1

NCT ID: NCT03568136 Completed - Dermatitis, Atopic Clinical Trials

Investigation of Efficacy of Secukinumab in Patients With Moderate to Serve Atopic Dermatitis

Secu_in_AD
Start date: September 18, 2018
Phase: Phase 2
Study type: Interventional

The overall aim of this study is to assess the effects of a new treatment called Secukinumab in adults suffering from moderate to severe atopic dermatitis. Furthermore, the study shall support the extension of the approval for Secukinumab from psoriasis to atopic dermatitis. The effectiveness of Secukinumab is determined on the reduction of the eczema score EASI 50 (Eczema Area and Severity Index, a tool to measure the severity of atopic dermatitis) at week 4.